LivaNova Competitors or Alternatives

LivaNova's top competitors include Terumo Medical, Medtronic and Haemonetics.

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

LivaNova's company profile

Vladimir A. Makatsaria

CEO

82/100
2,900
$125M
$1.3B
1
LivaNova's Competitor - Terumo Medical logo

CEO

- -
1,000 - 5,000
- -
$100M - 500M
2
LivaNova's Competitor - Medtronic logo

Geoffrey S. Martha

Chairman & CEO

70/100
95,000
$3.4B
$33.2B
3
LivaNova's Competitor - Haemonetics logo

Christopher Simon

President & CEO

96/100
2,820
- -
$1.4B
4
LivaNova's Competitor - NeuroPace logo

Joel Becker

President & CEO

82/100
170
$489.4M
$79.9M
5
LivaNova's Competitor - Abiomed logo

Andrew J. Greenfield

President

82/100
1,000 - 5,000
$42.1M
$1B - 5B

LivaNova VS Terumo Medical

Terumo Medical is the top competitor of LivaNova. Terumo Medical was founded in 1921, and its headquarters is in Tokyo, Tochigi Prefecture. Like LivaNova, Terumo Medical also operates in the Health Care Equipment & Services field. Terumo Medical has 1,400 fewer employees than LivaNova.

LivaNova VS Medtronic

Medtronic is seen as one of LivaNova's top competitors. Medtronic was founded in Dublin 2, County Dublin} in 1949. Like LivaNova, Medtronic also works within the Health Care Equipment field. Compared to LivaNova, Medtronic generates $31.9B more revenue.

LivaNova VS Haemonetics

Haemonetics is LivaNova's #3 rival. Haemonetics's headquarters is in Boston, Massachusetts, and was founded in 1953. Like LivaNova, Haemonetics also operates in the Health Care Equipment & Services sector. Haemonetics generates 109% of LivaNova's revenue.

Frequently Asked Questions about LivaNova

  1. Who are LivaNova's top competitors?

    LivaNova's top 3 competitors are Terumo Medical, Medtronic, Haemonetics.
  2. Who is similar to LivaNova?

    Terumo Medical is the most similar to LivaNova. Medtronic and Haemonetics are also similar to LivaNova.
  1. Are LivaNova and Terumo Medical competitors?

    Yes, Terumo Medical is one of LivaNova’s top competitors.